Active13985205Private limited companyEly

DRUG DEVELOPMENT SOLUTIONS LIMITED

Significant control: Alliance Buyer Inc. (75–100%)

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Drug Development Solutions Limited: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Drug Development Solutions Limited sell?

Registered activity: Other professional, scientific and technical activities n.e.c. (SIC 74909). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy

Summary

Generated from filed data · no estimates

DRUG DEVELOPMENT SOLUTIONS LIMITED is an active private limited company (company number 13985205) incorporated on 17 March 2022, registered in Ely. Its registered activity is other professional, scientific and technical activities n.e.c. (SIC 74909). Accounts are on file at Companies House (full) but not yet parsed into this record.

There are 524 companies in other professional, scientific and technical activities n.e.c. in Cambridge with filed accounts; the median reports net assets of £7,519 and is 11 years old.

Ownership and control

1 active · 2 other

Alliance Buyer Inc.
corporate entity, United States · since 12 July 2022
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
75–100%
Lgc Limited
corporate entity, United Kingdom · since 17 March 2022 · ceased 12 July 2022
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
75–100%
persons with significant control statement · since 20 July 2022 · ceased 20 July 2022

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

Key dates

Incorporated: 17 March 20224 yrs ago
First accounts due: 17 December 20231042 days overdue
Confirmation statement due: 31 March 2027in 158 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

Activity

SIC 74909: Other professional, scientific and technical activities n.e.c.
Accounts type: Full

Financials

No accounts on record

Accounts exist on the register but their figures are not in this dataset yet.

Filing and accounts signals

Facts from the register · no rating

Incorporated two to five years agoIncorporated 17 March 2022
Accounts past their due dateDue 17 December 2023

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

Timeline

Newest first

31 Mar 2027Confirmation statement duein 158 days
17 Dec 2023First accounts due1042 days overdue
17 Mar 2022Incorporated

Similar companies in Cambridge

Same activity (other professional, scientific and technical activities n.e.c.), closest in incorporation date

All companies incorporated on 17 March 2022 · in Mar 2022.

Reminders for DRUG DEVELOPMENT SOLUTIONS LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.